zoladexhcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | HCP Website Home | Zoladex® (goserelin |
| Description | Zoladex® is the only GnRH agonist with FDA approval for premenopausal women with advanced breast Health care professionals can find out about Zoladex for their patients with advanced HR+ breast cancer, advanced prostate cancer, or |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 159.135.1.38 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
zoladexhcp.com Valuation
|
US$9,131,398
Last updated: 2023-05-13 13:27:36
zoladexhcp.com has Semrush global rank of 1,159,111. zoladexhcp.com has an estimated worth of US$ 9,131,398, based on its estimated Ads revenue. zoladexhcp.com receives approximately 1,053,623 unique visitors each day. Its web server is located in United States, with IP address 159.135.1.38. According to SiteAdvisor, zoladexhcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$9,131,398 |
| Daily Ads Revenue | US$8,429 |
| Monthly Ads Revenue | US$252,870 |
| Yearly Ads Revenue | US$3,034,434 |
| Daily Unique Visitors | 70,242 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| zoladexhcp.com. | A | 599 | IP: 159.135.1.38 |
| zoladexhcp.com. | NS | 3600 | NS Record: ns07.domaincontrol.com. |
| zoladexhcp.com. | NS | 3600 | NS Record: ns08.domaincontrol.com. |
HtmlToTextCheckTime:2023-05-13 13:27:36
| HCP Website Home | Zoladex® (goserelin implant) Indications Important Safety Information Prescribing Information (10.8 mg) Prescribing Information (3.6 mg) Zoladex® (goserelin implant) This site is intended for US health care professionals Go to patient site The Zoladex patient HR+ breast cancer Prostate cancer Endometriosis Dosing and administration Efficacy and safety Access and support Request a rep Menu HR+ breast cancer Prostate cancer Endometriosis Zoladex ® is the only GnRH agonist with FDA approval for premenopausal women with advanced breast cancer 1‑4 See the Zoladex patient Only ready-to-use biodegradable GnRH agonist implant 1-4 View administration guide Only GnRH agonist with survival data to support its indication in breast cancer 1-4 Explore efficacy data Only GnRH agonist with a suite of support services for patients with breast or prostate cancer Get savings and support details References ZOLADEX ® (goserelin implant) 3.6 mg [prescribing information]. Lake Forest, |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: Apache/2.4 Content-Type: text/html; charset=iso-8859-1 Date: Tue, 21 Dec 2021 12:05:02 GMT Location: https://www.zoladexhcp.com/ Transfer-Encoding: chunked Connection: Keep-Alive Set-Cookie: X-Mapping-ijmpjhec=3DB1A1F149E0E0C94488C290D8A820CB; path=/ HTTP/1.1 200 OK Server: Apache/2.4 Content-Type: text/html; charset=UTF-8 Strict-Transport-Security: max-age=15552000 Date: Tue, 21 Dec 2021 12:05:02 GMT Transfer-Encoding: chunked Connection: Keep-Alive Set-Cookie: X-Mapping-ijmpjhec=3DB1A1F149E0E0C94488C290D8A820CB; path=/ |
zoladexhcp.com Whois Information
Domain Name: ZOLADEXHCP.COM Registry Domain ID: 2135458136_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2017-06-20T16:46:21Z Creation Date: 2017-06-20T16:46:20Z Registry Expiry Date: 2022-06-20T16:46:20Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS07.DOMAINCONTROL.COM Name Server: NS08.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-24T07:50:51Z <<< |